Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of erythropoietin as an
add-on therapy to methylprednisolone in subjects with acute autoimmune optic neuritis.
Phase:
Phase 2
Details
Lead Sponsor:
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH